EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis

Yong Zhang, Yuanyuan Mi, Chunhui He

Thoracic Cancer · 2023

DOI: 10.1111/1759-7714.14993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2023. Verfasst von Yong Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐small cell lung cancer (NSCLC) is one of the most prevalent and severe malignant tumors in the world and its molecular mechanism is still unclear. In recent years, increasing evidence indicates the significant roles of circRNAs in NSCLC. It has been determined that 2‐methoxyestradiol (2‐MeOE2) exerts antitumor roles in many cancers. However, the molecular mechanism of 2‐MeOE2 in regulating the development of lung cancer needs further elucidation.

Methods

The expression levels of circ_0010235, microRNA‐34a‐5p (miR‐34a‐5p), and nuclear factor of activated T cells 5 (NFAT5) were detected by quantitative real‐time polymerase chain reaction (qRT‐PCR). Cell proliferation, apoptosis and invasion were detected by cell counting kit‐8 (CCK‐8), 5‐ethynyl‐2′‐deoxyuridine (EdU) assay, flow cytometry and transwell assays, respectively. The interaction between miR‐34a‐5p and circ_0010235 or NFAT5 was predicted by bioinformatic software and confirmed by dual‐luciferase reporter assay.

Results

Our data showed 2‐MeOE2 hindered cell proliferation, invasion and induced apoptosis in NSCLC, which could be reversed by upregulation of circ_0010235 and NFAT5 or miR‐34a‐5p knockdown. Circ_0010235 and NFAT5 expression levels were increased, and miR‐34a‐5p expression level was decreased in NSCLC tissues and cells. In addition, 2‐MeOE2 treatment suppressed the expression of circ_0010235 and NFAT5 while promoted the expression of miR‐34a‐5p. Furthermore, circ_0010235 functioned as a molecular sponge of miR‐34a‐5p to regulate NFAT5 expression. Knockdown of circ_0010235 or 2‐MeOE2 treatment constrained tumor growth in vivo, and circ_0010235 depletion enhanced the inhibitory effect of 2‐MeOE2 on tumor growth in vivo.

Conclusion

These findings demonstrated that 2‐MeOE2 retarded NSCLC progression by modulating the circ_0010235/miR‐34a‐5p/NFAT5 axis, thus providing a new perspective for 2‐MeOE2 treatment in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsHumans2-MethoxyestradiolCarcinogenesisCell Transformation, NeoplasticCell ProliferationTranscription Factors

Stichwörter der Autor:innen

2-MeOE2NFAT5circ_0010235miR-34a-5pnon-small cell lung cancer

Substanzen

2-MethoxyestradiolMicroRNAsNFAT5 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Department of Urology, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Department of Pharmacy, Affiliated Hospital of Jiangnan University, Wuxi, China.

Zitieren

APA

Zhang, Y., Mi, Y., & He, C. (2023). 2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis. Thoracic Cancer. https://doi.org/10.1111/1759-7714.14993

Vancouver

Zhang Y, Mi Y, He C. 2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis. Thoracic Cancer. 2023. doi:10.1111/1759-7714.14993

BibTeX
@article{Zhang2023,
  author = {Zhang, Yong and Mi, Yuanyuan and He, Chunhui},
  title = {2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis},
  journal = {Thoracic Cancer},
  year = {2023},
  doi = {10.1111/1759-7714.14993}
}
Kostenlos starten →